GGA2 Knockout Raji Polyclonal Cells comprise a CRISPR/Cas9-edited polyclonal population of Raji B lymphocytes featuring disruption of the GGA2 gene locus, providing a loss-of-function model to investigate endosomal trafficking pathways. This product eliminates functional GGA2 protein expression across the cell pool, enabling comprehensive dissection of clathrin adaptor?Cdependent sorting events without clonal artifacts. The polyclonal format preserves cellular heterogeneity inherent to the Raji line, supporting robust and reproducible analyses of cargo transport and receptor dynamics in a neoplastic B-cell background.
The Raji host cell line is a widely characterized model originating from a Burkitt lymphoma patient, immortalized by Epstein-Barr virus and bearing the hallmark t(8;14) chromosomal translocation that juxtaposes c-Myc with the immunoglobulin heavy-chain locus. These cells exhibit a mature B-lymphocyte phenotype and maintain active endolysosomal and secretory pathways. Their rapid proliferation and genetic stability make them ideally suited for gene-editing approaches aimed at dissecting molecular mechanisms underpinning B-cell homeostasis, transformation, and receptor-mediated signaling.
GGA2 (Golgi-associated, gamma-adaptin ear?Ccontaining, ARF-binding protein 2) functions as a monomeric clathrin adaptor at the trans-Golgi network, where its VHS domain recognizes acidic dileucine motifs on transmembrane cargo such as cation-independent mannose 6-phosphate receptor (CI-MPR), epidermal growth factor receptor (EGFR), sortilin, and Notch. Binding of ARF1-GTP and ARF3 via its GAT domain recruits GGA2 to Golgi membranes enriched in phosphatidylinositol 4-phosphate (PI4P), promoting vesicle formation and delivery to early endosomes. The protein interacts with clathrin heavy chain, the AP-1 complex, gamma-synergin, epsinR, and rabaptin-5, linking cargo selection to Rab5- and ESCRT-I-dependent sorting. Through these interactions, GGA2 regulates lysosomal enzyme trafficking, receptor recycling, and downregulation of signaling receptors such as EGFR and LRP1.
In the Raji context, GGA2 disruption abrogates efficient delivery of lysosomal hydrolases and alters surface expression of CI-MPR and EGFR, potentially perturbing B-cell receptor signaling and antigen presentation. The model is instrumental for studying how Golgi-to-endosome transport defects contribute to lymphomagenesis and for evaluating lysosomal dysfunction as a therapeutic vulnerability in EBV-driven malignancies. Co-culture experiments and immunophenotyping can reveal compensatory adaptations in the absence of this key adaptor, offering insights into clathrin-independent trafficking routes active in B lymphocytes.
Researchers can employ these polyclonal knockout cells to quantify cargo mislocalization via immunofluorescence (TGN46, LAMP1 colocalization), measure surface receptor dynamics by flow cytometry, assess lysosomal enzyme activity, and probe ARF1-GGA2 interactions by co-immunoprecipitation. Functional assays such as phospho-flow analysis of BCR signaling and RT-qPCR profiling of lysosomal gene expression further extend the utility of this system. The cells are suitable for drug screening campaigns targeting trafficking disorders and for genetic interaction studies using complementation with GGA2 variants. For additional details or to discuss custom configurations, please contact Ascent Research.
